It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their U.S.

Pharmaceutical manufacturers may need new models to maintain sustainable businesses and support patients who cannot afford ...

In much of the U.S., illegal cannabis outcompetes legal weed sold in licensed shops. For consumers, it can be difficult to ...

The last few days have been a rollercoaster for the pharmaceutical industry. Mexico and Canada were bracing themselves for ...

According to Grand View Research, the European and Middle Eastern drug screening markets are projected to grow significantly by 2030, with Europe expected to reach $3.6 billion and the Middle East and ...

The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower ...

Eli Lilly on Thursday suggested that demand for its popular diabetes and weight-loss treatments was not a concern, easing ...

U.S. President Donald Trump has repeatedly mentioned pharmaceuticals as another industry that could be targeted by tariffs, ...

Novo Nordisk's CEO is not worried about blockbuster semaglutide drugs being added to Medicare drug pricing negotiations this ...

In recent years, the pharmaceutical industry has undergone significant changes in the focus of its innovation, research and ...